Amgen Senior VP-Research and Development Joseph Miletich: An Interview With “The Pink Sheet” DAILY (Part 2 of 3)
Exec discusses his views on biogenerics and Amgen's development program for the novel monoclonal antibody denosumab.
Exec discusses his views on biogenerics and Amgen's development program for the novel monoclonal antibody denosumab.